Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
If you would like to find more about Hovione's full range of inhalation development services, particle engineering and development by design schedule a meeting with us.